🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

EU to launch new legal action against AstraZeneca over vaccine deliveries

Published 10/05/2021, 16:28
Updated 10/05/2021, 16:30
© Reuters. FILE PHOTO: Vial labelled "AstraZeneca coronavirus disease (COVID-19) vaccine" placed on displayed EU flag is seen in this illustration picture taken March 24, 2021. REUTERS/Dado Ruvic
AZN
-

BRUSSELS (Reuters) - The European Commission will start on Tuesday a second legal case against AstraZeneca (NASDAQ:AZN) over its delayed deliveries of COVID-19 vaccines, a spokesman for the EU executive said on Monday.

The move is mostly procedural after a first case was launched in April, an official familiar with the case said, adding however that this new legal action will allow the EU to seek possible financial penalties.

© Reuters. FILE PHOTO: Vial labelled

"Tomorrow the case against AstraZeneca on the merits will be introduced before the Belgian court," the commission's spokesman said.

The first legal action was about requesting faster deliveries, whereas the new one will concern the merit of the case.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.